PATENT CLAIM ANALYSIS

Application Number: 16206734
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "242000"]

Abstract:
Provided are articles of manufacture, compositions and methods for prophylaxis and/or therapy for disorders involving dizziness and/or vertigo. The articles of manufacture and compositions contain lamotrigen and/or bupropion. The compositions include pharmaceutical compositions which are intended to alleviate dizziness and/or vertigo. In certain aspects the disclosure includes articles of manufacture and kits which include printed material which provides an indication that the articles or compositions are intended to be used for prophylaxis and/or therapy of Meniere's Disease or a symptom thereof.

Claim (Index 7):
The method of  claim 3 , wherein the effective amount of bupropion or the pharmaceutically acceptable salt thereof is 150 mg to 300 mg.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.74
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14730740', '15808223', '13405202', '13478640', '15274529']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8156301772120567
- 35 USC 102 Novelty (BERT): 0.5813066337192367
- Combined Prediction Score: 0.7921978228627746
- Mean Citation Score: 369.375994
- Max Citation Score: 624.8358
- Similarity Product: 363.3550861603975

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test